Collaborate Disseminate
Prostate cancer needs testosterone to grow. In metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease, the cancer continues growing despite a reduction in testosterone brought about by chemical or surgical castration. … Continue reading FDA fast-tracks personalized therapy for hard-to-treat-prostate cancer
A new study has found that, in mouse models of prostate cancer, a compound extracted from sandalwood oil was effective in slowing the onset and growth of tumors and resulted in cell death. Further research will explore whether the extract can be used t… Continue reading Sandalwood oil extract an effective prostate cancer treatment in mice
A new study has found that a compound created by the body’s breakdown of a cancer drug has therapeutic properties. When combined with the original drug, the by-product produced a synergistic effect to inhibit prostate cancer cells; when used alone, it reduced the buildup of a toxic protein in the brain associated with Parkinson’s disease.
Tags: metabolism, Drug, Prostate cancer, Parkinson’s Disease
Continue reading Cancer drug by-product may be an untapped Parkinson’s treatment
A new study has found that a compound created by the body’s breakdown of a cancer drug has therapeutic properties. When combined with the original drug, the by-product produced a synergistic effect to inhibit prostate cancer cells; when used alone, it reduced the buildup of a toxic protein in the brain associated with Parkinson’s disease.
Tags: metabolism, Drug, Prostate cancer, Parkinson’s Disease
Continue reading Cancer drug by-product may be an untapped Parkinson’s treatment
A new study has found that digital rectal examination alone or in combination with a blood test does not improve prostate cancer detection compared to the blood test alone. The findings suggest that digital exams are less effective than thought and cou… Continue reading Study gives digital prostate exams the finger as cancer screening tool
Researchers have identified the gene responsible for setting off a cellular chain reaction that causes prostate cancer to metastasize to the bone, making it almost impossible to treat. The discovery could have significant implications for treating pros… Continue reading Genetic ringleader responsible for prostate cancer spread identified
Researchers have uncovered the molecular mechanism that drives an aggressive form of prostate cancer that doesn’t respond well to typical treatments. Importantly, they also identified a drug currently undergoing clinical trials that can potentially tre… Continue reading Promising new approach targets aggressive type of prostate cancer
Researchers have identified three new prostate cancer biomarkers that improve the visibility of cancer cells used by pathologists to grade the disease’s severity. The novel technique could assist in determining which patients require urgent treatment a… Continue reading New prostate cancer biomarkers to help improve diagnosis and treatment
Men of African descent are known to have a far higher incidence of prostate cancer than other men. A new meta-analysis, the largest to date, has shed light on why this is so, identifying nine new genetic variants that increase the risk of prostate canc… Continue reading Largest study of its kind finds new genetic links to prostate cancer
The prevalence of prostate cancer around the world means that finding an effective treatment is critical. A new UK study has used mathematics to investigate the effectiveness of some currently available prostate cancer treatments.Continue ReadingCatego… Continue reading Math used to help calculate more effective prostate cancer treatments